Video
22 Jan 2024
Tablet and Capsule manufacturing plant.
JPG 519 kB
Our facilities are equipped with the latest and most sophisticated equipment and technology. Adhering to ISO 9001:2015 and ISO 14001:2015 standards, we comply with the latest WHO norms and GMP, ensuring the highest quality in all our products
Content provided by our supplier
Crassula Pharmaceuticals
-
US -
2023On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Other Content from Crassula Pharmaceuticals (1)
-
News Crassula Pharmaceuticals Launches Relixib, Etoricoxib 120mg, in Honduras
Tegucigalpa, Honduras – Crassula Honduras, a leading pharmaceutical manufacturer renowned for its commitment to quality, is excited to announce the introduction of Relixib, an etoricoxib 120mg tablet, to the Honduran market. This new addition to Crassula’s portfolio reinforces the company’s dedication to providing advanced healthcare solutions and addressing the needs of patients suffering from chronic pain and inflammation.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance